Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases

Qian Huang(Jiangnan University), Yi Huang(Jiangnan University)
Science Advances
March 29, 2024
10.1126/sciadv.adk1200
Cited by 133

Related Papers

Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7
|Cell Reports Medicine|2023|46
The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation
|Frontiers in Pharmacology|2017|9